From: The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
All Nodules | OR | CI − | CI+ | p-value |
TSH > 4 | 2.13 | 0.97 | 4.66 | 0.0666 |
TSH < 0.4 | 0.46 | 0.22 | 0.95 | 0.0500 |
fT4 > 16 | 2.10 | 1.09 | 4.06 | 0.0339 |
fT4 < 10 | 0.45 | 0.20 | 0.98 | 0.0603 |
fT3 > 5.5 | 0.39 | 0.14 | 1.12 | 0.107 |
fT3 < 3 | 1.83 | 0.25 | 13.69 | 0.605 |
fT4/fT3 > 3.3 | 6.00 | 2.56 | 14.07 | 0.0001 |
2–2.9 cm Nodules | OR | CI+ | CI − | p-value |
fT4 > 16 | 2.57 | 0.60 | 11.04 | 0.262 |
fT4 < 10 | 0.44 | 0.10 | 2.00 | 0.349 |
fT4/fT3 > 3.3 | 5.20 | 1.13 | 23.89 | 0.0610 |
3 –3.9 cm Nodules | OR | CI+ | CI − | p-value |
TSH > 4.4 | 4.75 | 0.68 | 33.14 | 0.165 |
TSH < 0.4 | 1.13 | 0.29 | 4.48 | 0.875 |
fT4 > 16 | 2.96 | 0.40 | 22.105 | 0.351 |
fT4 < 10 | 2.13 | 0.27 | 16.87 | 0.529 |
fT4/fT3 > 3.3 | 5.83 | 1.12 | 30.37 | 0.0640 |
>3.9 cm Nodules | OR | CI+ | CI − | p-value |
TSH < 0.4 | 0.78 | 0.13 | 4.85 | 0.234 |
fT4 > 16 | 0.93 | 0.22 | 4.02 | 0.935 |
fT3 > 5.5 | 0.70 | 0.06 | 8.69 | 0.803 |
fT3 < 3 | 0.75 | 0.06 | 9.87 | 0.846 |
fT4/fT3 > 3.3 | 9.60 | 1.16 | 79.41 | 0.0640 |